Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background: There is debate in the literature as to whether inclusion of a placebo arm may alter characteristics of antidepressant trials. However, previous research has focused on response rates of various antidepressants on average only, ignoring potential differences among drugs or other aspects of trial findings. Little is known about the impact of a placebo arm on all-cause dropout and dropout due to adverse events. Methods: We carried out a systematic review of published and unpublished double-blind randomized controlled trials (RCTs) for the acute treatment of unipolar major depression (update: January 2016). The probability of being allocated to placebo (π) was the exposure of interest, and we examined its influence on responders (efficacy), all-cause dropouts (acceptability) and dropouts due to adverse events (tolerability), while accounting for differences in drugs, trials and patient characteristics in multivariate random effects meta-regression. Results: We included 421 studies (68 305 participants) comparing 16 antidepressants or placebo; π ranged from 20% to 50%. Response rate was lower [risk ratio (RR) 0.87; 95% confidence interval (CI) 0.83, 0.92] and all-cause dropout rate higher (RR 1.19; 95% CI 1.08, 1.31) for the same antidepressants in placebo-controlled trials compared with head-to-head trials. The probability of responding decreased by 3% (95% CI 2-5%) for every 10% increase in π, whereas the risk of all-cause dropout increased by 4% (95% CI 1-7%). Tolerability was unaffected by π. Response rate was inversely correlated with dropouts due to any cause (correlation coefficient -0.48; 95% CI -0.58, -0.36) and due to adverse events (-0.34; 95% CI -0.44, -0.23). Conclusions: For the same antidepressant, response rate was on average smaller and dropouts higher when placebo was included; however, no association was found with dropouts due to adverse events. Decreased patient expectations, larger dropout rates and use of inappropriate statistical methods to impute missing data may explain this phenomenon. The findings call for caution in the integration of randomized evidence involving placebo arms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Self-citationCipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Self-citationControlling the risk of spurious findings from meta-regression
Higgins, J. P. T., & Thompson, S. G. (2004) · Statistics in Medicine · doi:10.1002/sim.1752 · Cited by 1,267
Self-citationNonspecific medication side effects and the nocebo phenomenon
Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784 · cited 1×
“Patient expectations could also be responsible for high rates of adverse events, even in patients who do not receive an active treatment (‘the nocebo phenomenon’).(10) Many factors can be associated with placebo response in antidepressant trials, such as baseline severity,(11) dosing schedule(12) and length of trial.”
Background(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.997 · Cited by 580
Meta-analysis of the placebo response in antidepressant trials.
Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J., & Hofmann, S. G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.029 · Cited by 346
Imputing response rates from means and standard deviations in meta-analyses
Furukawa, T. A., Cipriani, A., Barbui, C., Brambilla, P., & Watanabe, N. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00010 · Cited by 337
Self-citationBowling, A., Rowe, G., Lambert, N., Waddington, M., Mahtani, K., Kenten, C., Howe, A., & Francis, S. (2012) · Health Technology Assessment · doi:10.3310/hta16300 · Cited by 326
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318 · cited 1×
“A third explanation for the larger response rates in the head-to-head trials could be biases in conduct, analysis or reporting of these trials, driven by commercial interests.(27) This seems unlikely because funding by industry was not associated with important differences in response or dropout rates, in line with ou…”
ResultA practical introduction to multivariate meta-analysis
Mavridis, D., & Salanti, G. (2013) · Statistical Methods in Medical Research · doi:10.1177/0962280211432219 · Cited by 255
Self-citation
Cited by
Furukawa, T. A., Shinohara, K., Sahker, E., Karyotaki, E., Miguel, C., Ciharova, M., Bockting, C. L. H., Breedvelt, J. J. F., Tajika, A., Imai, H., et al. (2021) · World Psychiatry · doi:10.1002/wps.20906 · Cited by 126
Self-citationLee, S. M., Dong, T. S., Krause-Sorio, B., Siddarth, P., Milillo, M. M., Lagishetty, V., Datta, T., Aguilar-Faustino, Y., Jacobs, J. P., & Lavretsky, H. (2022) · International Psychogeriatrics · doi:10.1017/s1041610221000120 · Cited by 43
Mertens, L. J., Koslowski, M., Betzler, F., Evens, R., Gilles, M., Jungaberle, A., Jungaberle, H., Majić, T., Ströhle, A., Wolff, M., et al. (2022) · Neuroscience Applied · doi:10.1016/j.nsa.2022.100104 · Cited by 41
“Salanti et al. (2018) conclude from their fi ndings that the probability of receiving placebo should be considered when interpreting and synthesizing results from RCTs in major depression.”
Influential
Metadata
- Authors
- Salanti, G., Chaimani, A., Furukawa, T. A., Higgins, J. P. T., Ogawa, Y., Cipriani, A., & Egger, M.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-06
- Volume
- 47
- Issue
- 5
- Pages
- 1454-1464
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2806188084
- Cited by
- 46
- References
- 14
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis. https://app.cochat.ai/papers/10.1093/ije/dyy076
- The paper
- Salanti, G., Chaimani, A., Furukawa, T. A., Higgins, J. P. T., Ogawa, Y., Cipriani, A., & Egger, M. (2018). Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyy076
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.